Follow The Filings

STTK Shattuck Labs

Shattuck Labs earnings company data as of 4:46 AM ET 10/25

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by STTK's executives, directors and 10% owners in the last 12 months, from their Form 4s

All STTK insider trades
  • $250K bought by 1 insider
  • None no sales outside a trading plan
  • $592K sold by 2 insiders under 10b5-1 plans
  1. Abhinav A. Shukla Chief Technical Officer
    Planned sale
    $2,874 410 shares at $7.01 0.5% of stake
    Traded Jul 2 Filed Jul 7
  2. Abhinav A. Shukla Chief Technical Officer
    Planned sale
    $166K 23,465 shares at $7.08 21% of stake
    Traded Jun 30–Jul 1 Filed Jul 2
  3. Arundathy N. Pandite Chief Medical Officer
    Planned sale
    $210K 30,000 shares at $7.01 18% of stake
    Traded Jun 30 Filed Jul 2
  4. Clay B Siegall Director
    Buy
    $250K 62,500 shares at $4.00 +24% to stake
    Traded Jun 9 Filed Jun 11
  5. Abhinav A. Shukla Chief Technical Officer
    Planned sale
    $14K 2,032 shares at $7.01 2.4% of stake
    Traded May 12 Filed May 14
  6. Arundathy N. Pandite Chief Medical Officer
    Planned sale
    $198K 30,000 shares at $6.61 15% of stake
    Traded May 12 Filed May 14

Also filed in the last 12 months, not counted as buying or selling: 9 share withholdings for taxes, 5 stock grants, and 5 option exercises.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02
SCHEDULE 13D/A —
SCHEDULE 13G —
SCHEDULE 13D/A —
SCHEDULE 13D/A —
424B5
8-K 1.01,9.01
8-K 7.01,8.01,9.01
424B5
8-K 5.02,5.07,9.01
SCHEDULE 13G/A —
8-K 2.02
10-Q
DEF 14A
DEFA14A
10-K

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.